Vulnerability Description
MolecularFaces before 0.3.0 is vulnerable to cross site scripting. A remote attacker can execute arbitrary JavaScript in the context of a victim browser via crafted molfiles.
CVSS Score
MEDIUM
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Ipb-Halle | Molecularfaces | < 0.3.0 |
Related Weaknesses (CWE)
References
- https://github.com/advisories/GHSA-2pwh-52h7-7j84Third Party Advisory
- https://github.com/ipb-halle/MolecularFaces/security/advisories/GHSA-2pwh-52h7-7Vendor Advisory
- https://vulncheck.com/advisories/vc-advisory-GHSA-2pwh-52h7-7j84Third Party AdvisoryUS Government Resource
- https://github.com/advisories/GHSA-2pwh-52h7-7j84Third Party Advisory
- https://github.com/ipb-halle/MolecularFaces/security/advisories/GHSA-2pwh-52h7-7Vendor Advisory
- https://vulncheck.com/advisories/vc-advisory-GHSA-2pwh-52h7-7j84Third Party AdvisoryUS Government Resource
FAQ
What is CVE-2024-0758?
CVE-2024-0758 is a vulnerability with a CVSS score of 6.1 (MEDIUM). MolecularFaces before 0.3.0 is vulnerable to cross site scripting. A remote attacker can execute arbitrary JavaScript in the context of a victim browser via crafted molfiles.
How severe is CVE-2024-0758?
CVE-2024-0758 has been rated MEDIUM with a CVSS base score of 6.1/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2024-0758?
Check the references section above for vendor advisories and patch information. Affected products include: Ipb-Halle Molecularfaces.